Draft U.S. legislation would curb FDA medical software oversight

SAN FRANCISCO, Nov 24 (Reuters) - A draft U.S. bill is circulating in Washington D.C. that would curb the U.S. Food and Drug Administration's regulatory oversight over electronic medical records and some clinical support software, according to a copy of the legislation seen by Reuters.